Catto JWF - Search Results

1

Specificity of the Metallothionein-1 Response by Cadmium-Exposed Normal Human Urothelial Cells.

McNeill RV, Mason AS, Hodson ME, Catto JWF, Southgate J. McNeill RV, et al. Among authors: catto jwf. Int J Mol Sci. 2019 Mar 17;20(6):1344. doi: 10.3390/ijms20061344. Int J Mol Sci. 2019. PMID: 30884885 Free PMC article.

2

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.

Dudziec E, Gogol-Döring A, Cookson V, Chen W, Catto J. Dudziec E, et al. PLoS One. 2012;7(3):e32750. doi: 10.1371/journal.pone.0032750. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412920 Free PMC article.

3

MicroRNA and urothelial cell carcinoma.

Miah S, Pang K, Catto JW. Miah S, et al. BJU Int. 2014 May;113(5):811-2. doi: 10.1111/bju.12689. BJU Int. 2014. PMID: 24552448 No abstract available.

4

Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors.

Wang WT, Catto JW, Meuth M. Wang WT, et al. Oncogene. 2015 May 28;34(22):2887-96. doi: 10.1038/onc.2014.221. Epub 2014 Jul 21. Oncogene. 2015. PMID: 25043304

5

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.

Dhawan D, Hamdy FC, Rehman I, Patterson J, Cross SS, Feeley KM, Stephenson Y, Meuth M, Catto JW. Dhawan D, et al. J Pathol. 2006 Jul;209(3):336-43. doi: 10.1002/path.1991. J Pathol. 2006. PMID: 16639696

6

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.

Catto JW, Hartmann A, Stoehr R, Bolderson E, Rehman I, Rosario DJ, Hamdy FC, Meuth M. Catto JW, et al. J Urol. 2006 Jun;175(6):2323-30. doi: 10.1016/S0022-5347(06)00256-4. J Urol. 2006. PMID: 16697867

7

Behavior of urothelial carcinoma with respect to anatomical location.

Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O, Hamdy FC. Catto JW, et al. J Urol. 2007 May;177(5):1715-20. doi: 10.1016/j.juro.2007.01.030. J Urol. 2007. PMID: 17437794

8

Distinct microRNA alterations characterize high- and low-grade bladder cancer.

Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larré S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL, Hamdy FC. Catto JW, et al. Cancer Res. 2009 Nov 1;69(21):8472-81. doi: 10.1158/0008-5472.CAN-09-0744. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843843 Free PMC article.

9

Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.

Dudziec E, Miah S, Choudhry HM, Owen HC, Blizard S, Glover M, Hamdy FC, Catto JW. Dudziec E, et al. Clin Cancer Res. 2011 Mar 15;17(6):1287-96. doi: 10.1158/1078-0432.CCR-10-2017. Epub 2010 Dec 7. Clin Cancer Res. 2011. PMID: 21138856

10

Identification of differentially expressed long noncoding RNAs in bladder cancer.

Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon A, Chen W, Catto JW. Peter S, et al. Clin Cancer Res. 2014 Oct 15;20(20):5311-21. doi: 10.1158/1078-0432.CCR-14-0706. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page